Journal of Substance Abuse Treatment
Volume 27, Issue 4 , Pages 277-288 , December 2004

A randomized control trial of group counseling in a naltrexone treatment program

  • Thamizan Tucker, D.Psych (Clin)

      Affiliations

    • Turning Point Alcohol and Drug Centre, Inc., Fitzroy, Victoria, Australia
    • The University of Melbourne, Department of Psychology, Parkville, Victoria, Australia
    • Corresponding Author InformationCorresponding author. c/o Turning Point Alcohol and Drug Centre, Inc., 34-52 Gertrude Street, Fitzroy, Victoria, Australia, 3065. Tel.: +61 3 9766 3247; fax: +61 3 9766 3247
    • ,
  • Alison Ritter, Ph.D.

      Affiliations

    • Turning Point Alcohol and Drug Centre, Inc., Fitzroy, Victoria, Australia
    • ,
  • Claire Maher

      Affiliations

    • Turning Point Alcohol and Drug Centre, Inc., Fitzroy, Victoria, Australia
    • ,
  • Henry Jackson, Ph.D.

      Affiliations

    • The University of Melbourne, Department of Psychology, Parkville, Victoria, Australia

Received 29 September 2003 ,Revised 22 April 2004 ,Accepted 12 August 2004.

References 

  1. Abbott PJ, Weller SB, Delaney HD, Moore B. Community reinforcement approach in the treatment of opiate addicts. American Journal of Drug and Alcohol Abuse. 1998;24:17–30
  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: Author; 1994;
  3. Beck AT, Brown GK, Steer RA. Beck Depression Inventory II manual. San Antonio, TX: The Psychological Corporation; 1996;
  4. Brahen LS, Henderson RK, Capone T, Kordal N. Naltrexone treatment in a jail work-release program. Journal of Clinical Psychiatry. 1984;45:49–52
  5. Callahan E, Rawson R, McCleave B, Arias R, Glazer M, Liberman R. The treatment of heroin addiction: Naltrexone alone and with behaviour therapy. The International Journal of the Addictions. 1980;15:795–807
  6. Carroll KM. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Experimental Clinical Psychopharmacology. 1996;4:46–54
  7. Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713–727
  8. Christie MJ, Harvey AI. Pharmacological options for management of opioid dependence. Drug and Alcohol Review. 1993;12:71–80
  9. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.. Hillsdale, NJ: Erlbaum; 1988;
  10. Cohen J. A power primer. Psychological Bulletin. 1992;112:155–159
  11. Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment. 1997;14:529–534
  12. Darke S, Ward J, Hall W, Heather N, Wodak A. The Opiate Treatment Index (OTI) manual. Technical Report Number 11. National Drug and Alcohol Research Centre; 1991;
  13. Foy A, Sadler C, Taylor A. An open trial of naltrexone for opiate dependence. Drug and Alcohol Review. 1998;17:167–174
  14. Fram DH, Marmo J, Holden R. Naltrexone treatment: The problem of patient acceptance. Journal of Substance Abuse Treatment. 1989;6:119–122
  15. Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, et al. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. Journal of Substance Abuse Treatment. 1995;12:35–41
  16. Greenstein RA, Arndt IC, McLellan AT, O’Brien C, Evans P. Naltrexone: A clinical perspective. Journal of Clinical Psychiatry. 1984;45:25–28
  17. Haddock CK, Rindskopf D, Shadish WR. Using odds ratios as effect sizes for meta-analysis of dichotomous data: A primer on methods and issues. Psychological Methods. 1998;3:339–353
  18. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software; 1999;
  19. Kleber HD, Kosten TR. Naltrexone induction: psychologic and pharmacologic strategies. Journal of Clinical Psychiatry. 1984;45:29–38
  20. Lerner A, Sigal M, Bacalu A, Shiff R, Burganski I, Gelkopf M. A naltrexone double blind placebo controlled study in Israel. Israel Journal of Psychiatry and Related Science. 1992;29:36–43
  21. Ling W, Wesson DR. Naltrexone treatment for addicted health-care professionals: A collaborative private practice experience. Journal of Clinical Psychiatry. 1984;45:46–48
  22. In:  Marlatt GA,  Gordon JR editor. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford; 1985;
  23. McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959
  24. National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Archives of General Psychiatry. 1978;35:335–340
  25. O’Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry. 1996;53:217–224
  26. Onken L, Blaine J, Boren JJ. Integrating behavioral therapies with medications in the treatment of drug dependence (NIDA Research Monograph 150). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1995;
  27. Peachey JE, Lei H. Assessment of opioid dependence with naloxone. British Journal of Addiction. 1988;83:193–201
  28. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone compliance with contingency management. Drug and Alcohol Dependence. 1999;54:127–135
  29. Rawson RA, Ling W. Opioid addiction treatment modalities and some guidelines to their optimal use. Journal of Psychoactive Drugs. 1991;23:151–163
  30. Rawson RA, McCann MJ, Shoptaw SJ, Miotto KA, Frosch DL, Obert JL, et al. Naltrexone for opioid dependence: Evaluation of a manualised psychosocial protocol to enhance treatment response. Drug and Alcohol Review. 2001;20:67–78
  31. Roth A, Hogan I, Farren C. Naltrexone plus group therapy for the treatment of opiate-abusing health-care professionals. Journal of Substance Abuse Treatment. 1997;14:19–22
  32. Rothman RB, Gorelick DA, Heishman SJ, Eichmiller PR, Hill BH, Norbeck J, et al. An open-label study of a functional opioid ? antagonist in the treatment of opioid dependence. Journal of Substance Abuse Treatment. 2000;18:277–281
  33. San L, Pomarol G, Peri JM, Olle JM, Cami J. Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. British Journal of Addiction. 1991;86:983–990
  34. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction. 1995;90:415–424
  35. Tennant FS, Rawson RA, Cohen MA, Mann A. Clinical experience with naltrexone in suburban opioid addicts. Journal of Clinical Psychiatry. 1984;45:42–45
  36. Tucker TK, Ritter A. Naltrexone in the treatment of heroin dependence: A literature review. Drug and Alcohol Review. 2000;19:73–82
  37. In:  Ware J,  Kosinski M,  Keller S editor. SF-36 physical and mental health summary scales: a user’s manual. Boston: The Health Institute, New England Medical Centre; 1994;
  38. Ware J, Snow K, Kosinski M, Grandek B. SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute, New England Medical Centre; 1993;
  39. Washton AM, Pottash AC, Gold MS. Naltrexone in addicted business executives and physicians. Journal of Clinical Psychiatry. 1984;45:39–41
  40. Woody GE, McLellan AT, Luborsky L, O’Brien CP. Twelve-month follow-up of psychotherapy for opiate dependence. American Journal of Psychiatry. 1987;144:590–596
  41. Woody GE, McLellan AT, Luborsky L, O’Brien CP. Psychotherapy in community methadone programs: A validation study. American Journal of Psychiatry. 1995;152:1302–1308

PII: S0740-5472(04)00093-5

doi: 10.1016/j.jsat.2004.08.003

Journal of Substance Abuse Treatment
Volume 27, Issue 4 , Pages 277-288 , December 2004

Article Tools

* Image Usage & Resolution